Abstract
Sickle cell disorders are inherited hemolytic anemias, associated with the presence of Hemoglobin S. This group of disorders comprises homozygotes (HbSS), compound heterozygotes for hemoglobin C (HbSC) or β-thalassemia (Sβ thalassemia) (the most frequent associations) and, uncommonly, hemoglobin D (HbSD) and hemoglobin E (HbSE). This abnormal phenotype is caused by mutations in the Beta globin genes of both chromosomes 11. Thus, these disorders are recessively inherited and abnormalities in both alleles lead to structural defects in the beta-globin chain (HbS, HbC, HbD, HbE), or a reduction in its expression (thalassemia and HbE). Consequently, normal HbA, which is an α2β2 tetramer, is absent and substituted by the mutated hemoglobins, containing an α2β2 Mutated tetramer. Ultimately, the clinical phenotype is caused by the relatively high amounts of the α2β2 sickle tetramer, which allows hemoglobin polymerization and, in turn, leads to vasoocclusion, the hallmark of all sickle cell disorders. In this chapter, we will discuss clinical and laboratorial aspects of the compound sickle cell disorders SC, SD and Sβ thalassemia. In this book, sickle cell anemia is a synonymous for the homozygote state and it is approached elsewhere.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ambruso DR, Githens JH, Alcorn R et al (1987) Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 27(1):94–98
Ameen R, Al Shemmari S, Al-Bashir A (2009) Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion 49(8):1649–1654
Aygun B, Padmanabhan S, Paley C, Chandrasekaran V (2002) Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 42(1):37–43
Baldanzi G, Traina F, Marques Neto JF, Santos AO, Ramos CD, Saad ST (2011) Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease. Clinics (Sao Paulo) 66(5):801–805
Barros FB, Lima CS, Santos AO et al (2006) 51Cr-EDTA measurements of the glomerular filtration rate in patients with sickle cell anaemia and minor renal damage. Nucl Med Commun 27(12):959–962
Bezerra MAC (2009) Adhesive and functional properties of red blood cells, neurotrophils and platelets in patients with Hemoglobinopathy SC, Hb S-Beta thalassemia and thalassemia intermedia. Dissertation, University of Campinas, Brazil
Brandão MM (2005) Aplicação da pinça óptica para o estudo da deformabilidade das hemácias. Dissertation, University of Campinas, Brazil
Brandão MM, Fontes A, Barjas-Castro ML et al (2003) Optical tweezers for measuring red blood cell elasticity: application to the study of drug response in sickle cell disease. Eur J Haematol 70(4):207–211
Castro O, Sandler SG, Houston-Yu P, Rana S (2002) Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 42(6):684–690
Christakis J, Vavatsi N, Hassapopoulou H et al (1990) Comparison of homozygous sickle cell disease in northern Greece and Jamaica. Lancet 335(8690):637–640
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41
Colella MP, de Paula EV, Machado-Neto JA et al (2015) Elevated hypercoagulability markers in hemoglobin SC disease. Haematologica 100(4):466–471
Davies SC, McWilliam AC, Hewitt PE, Devenish A, Brozovic M (1986) Red cell alloimmunization in sickle cell disease. Br J Haematol 63(2):241–245
Elmariah H, Garrett ME, De Castro LM et al (2014) Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol 89(5):530–535
Fernandes AP, Januário JN, Cangussu CB, Macedo DL, Viana MB (2010) Mortality of children with sickle cell disease: a population study. J Pediatr 86(4):279–284
Fontes A, Barjas C-ML, Brandão MM et al (2011) Mechanical and electrical properties of red blood cells using optical tweezers. J Opt 13(1):044012
Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H (1999) Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 245(3):295–300
Kato GJ, Earles A, McGowan V, Machado RF et al (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107(6):2279–2285
Lane PA, O’Connell JL, Lear JL et al (1995) Functional asplenia in hemoglobin SC disease. Blood 85(8):2238–2244
Lasalle-Williams M, Nuss R, Le T et al (2011) Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 51(8):1732–1739
Mozar A, Grau M, Lamarre Y et al (2015) Red blood cell nitric oxide synthase activation is increased in patients with sickle cell hemoglobin C disease. Am J Hematol 90(2):E30–E32
Nagel RL, Steinberg MH (2009) Hemoglobin SC disease and Hb C disorders. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (eds) Disorders of hemoglobin genetics, pathophysiology, and clinical management, 2nd edn. Cambridge University Press, Cambridge, pp 756–785
Nagel RL, Fabry ME, Steinberg MH (2003) The paradox of hemoglobin SC disease. Blood Rev 17(3):167–178
Natukunda B, Schonewille H, Ndugwa C, Brand A (2010) Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 50(1):20–25
Novelli EM, Huynh C, Gladwin MT, Moore CG, Ragni MV (2012) Pulmonary embolism in sickle cell disease: a case–control study. J Thromb Haemost 10(5):760–766
Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Serjeant G (2001) Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 113(3):661–665
Orsini P, Rezende PV, Santos MV et al (2014) Estudo das Manifestações Clínicas e Hematológicas das Crianças com Hemoglobinopatia SD do Programa Estadual de Triagem Neonatal – PETN/NUPAD. In: XXIII Semana de Iniciação Científica da UFMG, 2014, Belo Horizonte. Anais eletrônicos da XXIII Semana de Iniciação Científica da UFMG
Osby M, Shulman IA (2005) Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 129(2):190–193
Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR (1991) Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325(1):11–16
Rodgers GP, Sahovic EZ, Pierce LE, Anagnou NP, Noguchi CT, Schechter AN (1986) Hemoglobin SC disease and alpha-thalassaemia. Prolonged survival and mild clinical course. Am J Med 80(4):746–750
Rosse WF, Gallagher D, Kinney TR et al (1990) Cooperative study of sickle cell disease transfusion and alloimmunization in sickle cell disease. Blood 76(7):1431–1437
Sakhalkar VS, Roberts K, Hawthorne LM et al (2005) Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci 1054:495–499
Saraf SL, Molokie RE, Nouraie M et al (2014) Differences in the clinical and genotypic presentation of sickle cell disease around the world. Paediatr Respir Rev 15(1):4–12
Serjeant GR, Serjeant BE (2011a) Sickle cell-haemoglobin C disease. In: Serjeant GR, Serjeant BE (eds) Sickle cell disease, 3rd edn. Oxford University Press, New York, pp 445–455
Serjeant GR, Serjeant BE (2011b) Other forms of sickle cell disease. In: Serjeant GR, Serjeant BE (eds) Sickle cell disease, 3rd edn. Oxford University Press, New York, pp 472–477
Stein PD, Beemath A, Meyers FA, Skaf E, Olson RE (2006) Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 119(10):897. e7–e11
Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD (1994) Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 34(7): 562–569
Vichinsky E (2001) Consensus document for transfusion-related iron overload. Semin Hematol 38(1 Suppl 1):2–4
Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322(23): 1617–1621
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Saad, S.T.O., Gilli, S.O. (2016). Hemoglobin Sβ Thalassemia, SC Disease and SD Disease: Clinical and Laboratorial Aspects. In: Costa, F., Conran, N. (eds) Sickle Cell Anemia. Springer, Cham. https://doi.org/10.1007/978-3-319-06713-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-06713-1_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06712-4
Online ISBN: 978-3-319-06713-1
eBook Packages: MedicineMedicine (R0)